Keya Medical
AI for Smarter Healthcare
CT FFR Analysis
Enhancing Diagnosis and Management for Coronary Artery Disease Patients
DEEPVESSEL FFR is a AI-enabled, non-invasive CT fractional flow reserve (FFRCT) analysis. It is an augmentative physiological functional assessment of the coronary arteries using coronary computer tomography angiograms. The software can reduce unnecessary invasive testing, improve patient safety, and lower the cost of cardiovascular testing.
A New Category I CPT code for non-invasive FFR
Category I CPT Code
Starting January 1, 2024, medical practices will implement a new category I CPT code (75580) for non-invasive FFR estimates derived from coronary CT angiography software analysis.
The American College of Cardiology (ACC), American College of Radiology (ACR), and the Society of Cardiovascular Computed Tomography (SCCT) jointly proposed this change to the American Medical Association. It replaces four prior category III CPT codes.
Available in the USA, EMEA, China, Singapore
CE-Marked
2018
NMPA-Approved
2020
FDA-Cleared
2022
HSA-Certified
2023
Advantages
Precise
Comprehensive
Cost Saving
Physician Autonomy
Streamlined Workflow
Efficient
FFRCT and DVFFR have transformed my practice, allowing me to provide superior patient care and achieve better outcomes. I am sincerely grateful for this invaluable resource provided by Corazon Imaging.
News
AI derived decision-making and assessment in CAD, Keya Medical sponsored webinar
AI derived decision-making and assessment in CADFree Online Sponsored webinar | SCCTThursday, March 20 | 12noon – 1pm ESTJoin us for a FREE online webinar featuring Armin Zadeh, MD, MSCCT; Michael Blaha, MD, MPH; Dinesh Kalra, MD, FSCCT and Irfan Shafique, MD...
Keya Medical and Dr. Irfan Shafique present DVFFR at SCCT Global 2025
At SCCT Global 2025, Dr. Irfan Shafique, delivered a presentation titled “AI in CTFFR Analysis and introduced DEEPVESSEL FFR, Keya Medical’s flagship AI-driven software designed to enhance non-invasive cardiac diagnostics.
Exploring the Future of Non-Invasive Cardiac Diagnostics: Keya at SCCT Global 2025
Keya Medical’s advanced AI solutions and the application of Deep Learning CT-derived Fractional Flow Reserve analysis in non-invasive cardiac diagnostics. Visit us at SCCT 2025, Booth 14.
